These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29028753)

  • 1. Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine.
    Padula WV; McQueen RB; Pronovost PJ
    Med Care; 2017 Nov; 55(11):909-911. PubMed ID: 29028753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine.
    Padula WV; McQueen RB; Pronovost PJ
    Med Care; 2017 Nov; 55(11):915-917. PubMed ID: 29028755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
    Sanders GD; Neumann PJ; Basu A; Brock DW; Feeny D; Krahn M; Kuntz KM; Meltzer DO; Owens DK; Prosser LA; Salomon JA; Sculpher MJ; Trikalinos TA; Russell LB; Siegel JE; Ganiats TG
    JAMA; 2016 Sep; 316(10):1093-103. PubMed ID: 27623463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response.
    Cohen JT; Wong JB
    Med Care; 2017 Nov; 55(11):912-914. PubMed ID: 29028754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.
    Siegel JE; Weinstein MC; Russell LB; Gold MR
    JAMA; 1996 Oct 23-30; 276(16):1339-41. PubMed ID: 8861994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Are the Strength of Recommendations and Methodologic Reporting in Health Economic Studies in Orthopaedic Surgery?
    Makhni EC; Steinhaus ME; Swart E; Bozic KJ
    Clin Orthop Relat Res; 2015 Oct; 473(10):3289-96. PubMed ID: 26024580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling".
    Zawadzki NK; Hay JW
    Int J Health Policy Manag; 2020 Aug; 9(8):352-355. PubMed ID: 32613807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.
    Carlson JJ; Walton SM; Basu A; Chapman RH; Campbell JD; McQueen RB; Pearson SD; Touchette DR; Veenstra D; Whittington MD; Ollendorf DA
    Pharmacoeconomics; 2019 Nov; 37(11):1321-1327. PubMed ID: 31485925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of abstracts of papers reporting original cost-effectiveness analyses.
    Rosen AB; Greenberg D; Stone PW; Olchanski NV; Neumann PJ
    Med Decis Making; 2005; 25(4):424-8. PubMed ID: 16061894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and quality of the cost-utility literature, 1976-2001.
    Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
    Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):e1-5. PubMed ID: 23538200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    J Med Econ; 2013; 16(6):713-9. PubMed ID: 23521434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open access mandate threatens dissemination of scientific information.
    McMullan E
    J Neuroophthalmol; 2008 Mar; 28(1):72-4. PubMed ID: 18347464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.